Physician profile
Paul E Noel
NPI 1093706210
$4,678.99
in general payments reported to CMS, 2019-2025
31 companies · $23.51 in 2025
The $23.51 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $963 · 2020: $409 · 2021: $655 · 2022: $1,827 · 2023: $617 · 2024: $184 · 2025: $23.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $823.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $668.26 | 2019-2024 | Collagenase Santyl |
| Kerecis Limited | $552.51 | 2022-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Davol INC. | $478.28 | 2019-2022 | |
| Acera Surgical, INC. | $382.99 | 2019-2021 | |
| Sanara Medtech INC. | $349.29 | 2022-2023 | Celleraterx |
| Stryker Corporation | $308.16 | 2022 | |
| Abbvie INC. | $247.02 | 2021-2022 | |
| Intuitive Surgical, INC. | $239.88 | 2019-2020 | |
| Cumberland Pharmaceuticals, INC. | $226.37 | 2021-2022 | |
| Integra Lifesciences Corporation | $218.63 | 2019-2021 | |
| Polynovo North America LLC | $157.17 | 2022-2023 | |
| Tela Bio, INC. | $145.94 | 2020-2022 | |
| Osiris Therapeutics INC. | $128.75 | 2019 | |
| Olympus America INC. | $106.59 | 2019-2022 | |
| Aroa Biosurgery Incorporated | $52.80 | 2023-2024 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $49.43 | 2021 | |
| Bard Peripheral Vascular, INC. | $46.31 | 2020-2022 | |
| Convatec INC. | $40.20 | 2022-2023 | |
| Paratek Pharmaceuticals, INC. | $37.41 | 2020 | |
| Nuvasive, INC. | $35.08 | 2019 | |
| Kci USA, INC. | $33.30 | 2019-2021 | |
| Melinta Therapeutics, LLC | $27.25 | 2023 | Orbactiv, Kimyrsa |
| Bioventus LLC | $23.35 | 2022 | |
| Coloplast Corp | $18.33 | 2022 | |
| Endogastric Solutions, INC | $18.17 | 2022 | |
| Ethicon US, LLC | $16.72 | 2021 | |
| Baxter Healthcare | $16.57 | 2022 | |
| Axonics, INC. | $15.20 | 2022 | |
| Si-Bone, INC. | $14.80 | 2020 | |
| Heron Therapeutics, INC. | $12.66 | 2022 | |
| Lemaitre Vascular, INC. | $11.57 | 2023 | Anastoclip Gc 8cm (Medium) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Noel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.